Page last updated: 2024-08-24

goralatide and Brain Emboli

goralatide has been researched along with Brain Emboli in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chopp, M; Ding, G; Jiang, Q; Rhaleb, NE; Teng, H; Yang, XP; Zhang, L; Zhang, ZG	1

Other Studies

1 other study(ies) available for goralatide and Brain Emboli

Article	Year
Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke. Stroke, 2014, Volume: 45, Issue:4 Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Therapy, Combination; Endothelial Cells; Fibrinolytic Agents; Growth Inhibitors; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Male; Neuroprotective Agents; NF-kappa B; Oligopeptides; Plasminogen Activator Inhibitor 1; Primary Cell Culture; Rats; Rats, Wistar; Stroke; Tissue Plasminogen Activator; Transforming Growth Factor beta1	2014

Article

Year

Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.

Stroke, 2014, Volume: 45, Issue:4

Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Therapy, Combination; Endothelial Cells; Fibrinolytic Agents; Growth Inhibitors; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Male; Neuroprotective Agents; NF-kappa B; Oligopeptides; Plasminogen Activator Inhibitor 1; Primary Cell Culture; Rats; Rats, Wistar; Stroke; Tissue Plasminogen Activator; Transforming Growth Factor beta1

2014